Ginsenoside Rc mitigates hippocampal neuronal damage and cognitive impairment in vascular dementia rats via the pY705-Stat3/Foxo3a and pS727-Stat3/GRIM-19 pathways.

ABSTRACT:

Background

Vascular dementia (VaD), the second most common cause of dementia, lacks effective treatments. Ginsenoside Rc (GRc) has demonstrated therapeutic potential, but its role in VaD remains unclear. This study investigates the protective effects of GRc in VaD and its underlying mechanisms.

Methods

Cognitive function was assessed using novel object recognition and Morris water maze tests. Neuronal and glial status in the cortex and hippocampus were evaluated by immunohistochemistry, Nissl staining, immunofluorescence, transmission electron microscopy, and Western blotting. Drug target identification was performed through molecular docking, molecular dynamics simulations, and cellular thermal shift assay. Apoptosis markers, along with pY705-Stat3/Foxo3a/Nrf2 and pS727-Sta

SUBMITTER: Wu Y 

PROVIDER: S-EPMC12629734 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature